OAM
CVS icon

Ostrum Asset Management’s CVS Health CVS Stock Holding History

Ostrum Asset Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.36M Buy
13,179
+50
+0.4% +$4.46K 0.07% 198
2026
Q1 		$943K Sell
13,129
-6,094
-32% -$469K 0.05% 226
2025
Q4 		$1.53M Sell
19,223
-1,086
-5% -$85.6K 0.07% 207
2025
Q3 		$1.53M Buy
20,309
+7,709
+61% +$528K 0.07% 236
2025
Q2 		$869K Sell
12,600
-1,484
-11% -$97.3K 0.04% 326
2025
Q1 		$954K Sell
14,084
-31,795
-69% -$1.9M 0.05% 302
2024
Q4 		$2.06M Buy
45,879
+833
+2% +$46.7K 0.18% 190
2024
Q3 		$2.83M Sell
45,046
-7,974
-15% -$465K 0.23% 144
2024
Q2 		$3.13M Sell
53,020
-2,027
-4% -$127K 0.27% 110
2024
Q1 		$4.39M Buy
55,047
+740
+1% +$56.5K 0.35% 70
2023
Q4 		$4.29M Sell
54,307
-5,601
-9% -$399K 0.37% 70
2023
Q3 		$4.18M Buy
59,908
+6,066
+11% +$430K 0.39% 57
2023
Q2 		$3.72M Sell
53,842
-257
-0.5% -$18.3K 0.31% 90
2023
Q1 		$4.02M Buy
+54,099
New +$4.54M 0.35% 76

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Ostrum Asset Management's CVS Position: Q2 2026 in Review

Ostrum Asset Management increased its CVS Health (CVS) stake by 0.38% in Q2 2026, buying an estimated $4.46K and bringing the position to 13,179 shares worth $1.36M. The position accounts for 0.07% of the portfolio, ranked #198.

Ostrum Asset Management first reported a position in CVS in Q1 2023 and has held it in 14 quarters since. The position peaked at $4.39M in Q1 2024. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Ostrum Asset Management held 13,179 shares of CVS Health worth $1.36M as of Q2 2026.
  • Ostrum Asset Management bought 50 CVS Health shares in Q2 2026, an estimated $4.46K.
  • CVS Health made up 0.07% of Ostrum Asset Management's portfolio in Q2 2026, its #198 holding.
  • Ostrum Asset Management first reported a position in CVS Health in Q1 2023 and has held it in 14 quarters since.
  • Ostrum Asset Management's CVS Health position peaked at $4.39M in Q1 2024.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Ostrum Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.